Revenue: The sum of all revenue fields included for a company's operating activities.
Arrowhead Pharmaceuticals, Inc. (ARWR) had Revenue of $3.55M for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
|
Revenue |
$3.55M |
$-599.49M |
|
-- |
|
$3.55M |
|
$604.63M |
|
$-601.08M |
|
$-11.38M |
|
$-612.46M |
|
$-612.46M |
|
$-609.69M |
|
$-609.69M |
|
$-609.69M |
|
$-609.69M |
|
$-601.08M |
|
$-585.73M |
|
119.78M |
|
119.78M |
|
$-5.00 |
|
$-5.00 |
|
| Balance Sheet Financials | |
$695.47M |
|
$386.03M |
|
$444.33M |
|
$1.14B |
|
$103.17M |
|
$393.18M |
|
$845.57M |
|
$948.74M |
|
$191.06M |
|
$182.50M |
|
$191.06M |
|
124.38M |
|
| Cash Flow Statement Financials | |
$-462.85M |
|
$-420.07M |
|
$870.52M |
|
$110.89M |
|
$102.69M |
|
$-8.21M |
|
$73.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.74 |
|
-- |
|
-- |
|
0.67 |
|
2.06 |
|
100.00% |
|
-16927.06% |
|
-16927.06% |
|
-16494.76% |
|
-17247.54% |
|
-16882.37% |
|
$-604.32M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-319.11% |
|
-334.08% |
|
-53.49% |
|
-104.36% |
|
$1.54 |
|
$-5.05 |
|
$-3.86 |
|